CIRM's Thomas: Conflicts 'Put to Bed' at Stem Cell Agency
The chairman of the $3 billion California stem cell agency, Jonathan Thomas, today hailed board action last week as putting “to bed once and for all” questions about financial conflicts of interest by members of the agency's governing board.
Writing on the agency's blog, Thomas pointed to board approval of a new policy that would bar 13 of the 29 members…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.